Targeted radiotherapy reduces mortality for early-stage lung cancer

Stereotactic body radiotherapy conferred lower 30-day and 90-day mortality rates than surgery among patients with early-stage non-small cell lung cancer, according to study results. The difference appeared more prominent among patients aged older than 70 years.
Healio